Target intelligence / Profile preview

Phosphodiesterase 4A (PDE4A) and Phosphodiesterase 4B (PDE4B) (PDE4A, PDE4B)

Target
PDE4A, PDE4B
Molecular classification
Enzyme, Cyclic nucleotide phosphodiesterase
01

Overview

Phosphodiesterase 4A and 4B are members of the PDE4 enzyme subfamily, which hydrolyze intracellular cAMP to 5'-AMP, acting as key regulators of cellular signaling in neurons, immune cells, and other tissues. These enzymes are encoded by separate genes and have multiple isoforms defined by alternative splicing and post-translational modifications. PDE4A is primarily membrane-associated and localized to the brain, especially in regions associated with learning and memory, while PDE4B is broadly expressed and implicated in inflammatory signaling. Selective inhibition of PDE4A/B increases cAMP, modulating various physiological processes and providing therapeutic effects in neurodegenerative, psychiatric, and inflammatory diseases. Isoform-specific localization and function are determined by distinct N-terminal sequences and post-translational modifications, which further control subcellular compartmentalization and signaling specificity.

Other names
PDE4APDE4BcAMP-specific phosphodiesterase 4AcAMP-specific phosphodiesterase 4BcAMP PDE4A/B
02

Mechanism of action

Inhibition of cAMP breakdown, leading to increased cAMP signaling in target tissues. Regulation of cAMP-dependent protein kinase A (PKA) and downstream transcription factors (e.g., CREB).

03

Biological functions

Signal transductionRegulation of cyclic AMP levelsModulation of memory and learningRegulation of inflammatory response
04

Disease associations

InflammationNeurodegenerative disease (e.g., cognitive dysfunction, Alzheimer's disease)DepressionOther psychiatric and neurological disorders
05

Safety considerations

Nausea, emesis (major dose-limiting side effect in humans)Psychiatric side effects with chronic usePotential immunosuppression (with long-term inhibition)
06

Interacting drugs

Rolipram

3 more in the full profile.

Beyond the preview

Go deeper on Phosphodiesterase 4A (PDE4A) and Phosphodiesterase 4B (PDE4B) (PDE4A, PDE4B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphodiesterase 4A (PDE4A) and Phosphodiesterase 4B (PDE4B) (PDE4A, PDE4B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call